Kaleido Biosciences KLDO
$ 0.29
-3.69%
Annual report 2021
added 12-23-2023
Country |
USA |
IPO year |
2019 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Mr. Mike Bonney |
Employees in the company |
91 |
Shares |
41.9 M |
Market Cap[1] |
$ 12.4 M |
EBITDA (LTM) |
$ -88.1 M |
P/E (LTM) |
-0.12 |
P/S (LTM) |
11.34 |
EPS (LTM) |
-2.33 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.